RuxolitinibEpstein-Barr-virus reactivation and secondary lymphoproliferative disorder: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1795卷 / 1期

关键词：

D O I：

10.1007/s40278-020-76265-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：244 / 244

相关论文

共 50 条

[1] RuxolitinibEpstein-Barr virus infection reactivation: case report
Reactions Weekly, 2023, 1976 (1) : 300 - 300
[2] MethotrexateSystemic lymphadenopathy as a lymphoproliferative disorder secondary to Epstein-Barr virus reactivation: case report
Reactions Weekly, 2020, 1815 (1) : 197 - 197
[3] MethotrexatePrimary hepatic lymphoproliferative disorder associated with Epstein-Barr virus reactivation: case report
Reactions Weekly, 2023, 1949 (1) : 277 - 277
[4] MethotrexateAccelerated rheumatoid nodulosis, lymphoproliferative disorder and Epstein-Barr virus reactivation: case report
Reactions Weekly, 2015, 1573 (1) : 156 - 156
[5] Multiple drugsEpstein-Barr virus reactivation and EBV driven lymphoproliferative disorder: case report
Reactions Weekly, 2017, 1655 (1) : 178 - 178
[6] Antithymocyte globulinPost transplant lymphoproliferative disorder and reactivation of Epstein-Barr virus infection: case report
Reactions Weekly, 2017, 1673 (1) : 57 - 57
[7] RuxolitinibEpstein-Barr virus gastric ulcer: case report
Reactions Weekly, 2016, 1621 (1) : 231 - 231
[8] MethotrexateEpstein–Barr virus positive lymphoproliferative disorder: case report
Reactions Weekly, 2019, 1767 (1) : 215 - 215
[9] ImmunosuppressantsEpstein-Barr virus reactivation-related post-transplant lymphoproliferative disorder: case report
Reactions Weekly, 2020, 1834 (1) : 134 - 134
[10] Antithymocyte-globulinEpstein Barr virus reactivation leading to post-transplant lymphoproliferative disorder: case report
Reactions Weekly, 2018, 1733 (1) : 57 - 57

← 1 2 3 4 5 →